This series on “The development new agents in T-cell lymphoma” is edited by Dr. Michinori Ogura, Director of Department of Hematology, Head of Department of Clinical Trial Management, Tokai Central Hospital, Kakamigahara, Gifu, Japan, and by Dr. Pier Luigi Zinzani, Professor of Hematology, Head of Lymphoma Group, Institute of Hematology, “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy.

This series is designed to discuss current topics in the development new agents in T-cell lymphoma. This series aims to provide an updated overview of the most recent acquisitions and future perspectives.

Disclosure:
The series “The development new agents in T-cell lymphoma” was commissioned by the editorial office, Annals of Lymphoma without any sponsorship or funding. Michinori Ogura and Pier Luigi Zinzani, served as the unpaid Guest Editors for the series.